Articles

Sequester hits U.S. researchers hard

With 5 percent of its budget gone, NIH outlines grim state of U.S. biomedical research funding
Written byAmy Swinderman
| 4 min read

WASHINGTON, D.C.—With the sequester, or $85 billion inacross-the-board cuts to government spending, now a stark reality, the U.S.National Institutes of Health (NIH) has issued data on the expected impact thefunding cuts will have on American biomedical research—and the news is grim.

With U.S. lawmakers failing to reach a budget compromise, thesequester went into effect on March 1—and the NIH immediately lost $1.6 billionof its already stretched-thin $30-billion budget for fiscal year 2013.

Although the research community held out hope for passage ofa proposal by President Barack Obama to cancel the sequester and replace itwith a plan that would have given the NIH $31 billion—only a slight increaseover what the agency got prior to the sequester—this alternative plan was notto be. With the sequester still in place, the NIH must cut 5 percent, or $1.55billion, of its budget this year. The cuts apply to all programs, projects andactivities of the NIH's Institutes and Centers (ICs).

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.